Ethinylestradiol benzoate: Difference between revisions
CSV import |
No edit summary |
||
| Line 23: | Line 23: | ||
[[Category:Pharmaceuticals]] | [[Category:Pharmaceuticals]] | ||
{{Pharm-stub}} | {{Pharm-stub}} | ||
== Ethinylestradiol_benzoate == | == Ethinylestradiol_benzoate == | ||
<gallery> | <gallery> | ||
File:Ethinylestradiol_benzoate.svg|Ethinylestradiol benzoate | File:Ethinylestradiol_benzoate.svg|Ethinylestradiol benzoate | ||
</gallery> | </gallery> | ||
Latest revision as of 20:53, 16 March 2025
Ethinylestradiol benzoate is a synthetic, steroidal estrogen that is derived from estradiol. It is a long-acting estrogen, and is an estrogen ester, specifically, the 3-benzoate ester of ethinylestradiol. Ethinylestradiol benzoate is used in medicine for hormone therapy.
Pharmacology[edit]
As a form of estrogen, ethinylestradiol benzoate binds to and activates the estrogen receptor, a type of nuclear receptor that is activated by the hormone estrogen. This results in changes in gene expression which can lead to a variety of effects, including the development of female secondary sexual characteristics and the regulation of the menstrual cycle.
Medical uses[edit]
Ethinylestradiol benzoate is used in hormone therapy for menopausal symptoms, hypogonadism, prostate cancer, and for other conditions. It is also used in hormonal contraception, specifically in combination with a progestogen.
Side effects[edit]
Like all estrogens, ethinylestradiol benzoate has a number of potential side effects. These can include nausea, breast tenderness, fluid retention, and an increased risk of thrombosis. It can also cause changes in mood and libido.
See also[edit]
Ethinylestradiol_benzoate[edit]
-
Ethinylestradiol benzoate
